Christopher O'Callaghan

Research

Clinical Trial Gastroesophageal Cancer Her 2 Positive Esophagectomy Radiotherapy Randomized Trial Squamous Cell Carcinoma Esophagus

Latest funding

Predictive biomarkers for adjuvant immune checkpoint inhibitor therapy in non-small cell lung cancer
CIHR · 2022 · Co-investigator
$1,224,000
An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial
CIHR · 2022 · Principal investigator
$1,813,050
X-chromosome wide genetic association on cancer prognostic and pharmacogenetic analysis of clinical trials: methodological development and analysis
CIHR · 2015 · Co-investigator
$150,000

All 3 grants and awards

Predictive biomarkers for adjuvant immune checkpoint inhibitor therapy in non-small cell lung cancer

Co-investigatorCIHR2022Project Grant

Principal investigators: Tsao, Ming-Sound; Goss, Glenwood D

Keywords: Adjuvant Therapy; Gene Expression Signature; Immune Checkpoint Inhibitor; Immunohistochemistry; Multiplex Immunostaining; Mutation; Non-Small Cell Lung Cancer; Pd-L1; Predictive Marker; Prognostic Marker

$1,224,000

An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial

Principal investigatorCIHR2022Project Grant

Principal investigators: Lukovic, Jelena; O'Callaghan, Christopher J

Keywords: Esophagectomy; Radiotherapy; Randomized Trial; Squamous Cell Carcinoma Esophagus

$1,813,050

X-chromosome wide genetic association on cancer prognostic and pharmacogenetic analysis of clinical trials: methodological development and analysis

Co-investigatorCIHR2015Catalyst Grant: Sex as a Variable in Biomedical Research

Principal investigators: Xu, Wei; Liu, Geoffrey

Keywords: Clinical Trial; Gwas; Sex; Statistical Methdology; Survival

$150,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2022

Subject: Prospective PhD student: Clinical Trial Dear Professor O'Callaghan, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on clinical trial connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "An international randomized trial on neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma versus definitive chemoradiotherapy with salvage surgery as needed - The NEEDS Trial" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]